A cohort study of the risk of cancer associated with type 2 diabetes

A cohort study of the risk of cancer associated with type 2 diabetes

Background: There is evidence to suggest that diabetes may increase the risk of incidence and mortality from cancer. Methods: In a cohort study using record-linkage health-care datasets for Tayside, Scotland in 1993–2004, we followed up 9577 newly diagnosed patients with type 2 diabetes, and two mat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of cancer 2009-10, Vol.101 (7), p.1199-1201
Hauptverfasser: Ogunleye, A A, Ogston, S A, Morris, A D, Evans, J M M
Format: Artikel
Sprache:eng
Schlagworte:
Biological and medical sciences
Biomedical and Life Sciences
Biomedicine
Cancer Research
Cohort analysis
Cohort Studies
Colon
Colonic Neoplasms - etiology
Datasets
Diabetes
Diabetes Mellitus, Type 2 - complications
Diabetes. Impaired glucose tolerance
Drug Resistance
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Epidemiology
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Female
Humans
Liver
Liver Neoplasms - etiology
Male
Medical diagnosis
Medical research
Medical sciences
Middle Aged
Molecular Medicine
Mortality
Neoplasms - epidemiology
Neoplasms - etiology
Oncology
Pancreatic Neoplasms - etiology
Patients
Risk
Scotland - epidemiology
Short Communication
Survival analysis
Time Factors
Tumors
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: There is evidence to suggest that diabetes may increase the risk of incidence and mortality from cancer. Methods: In a cohort study using record-linkage health-care datasets for Tayside, Scotland in 1993–2004, we followed up 9577 newly diagnosed patients with type 2 diabetes, and two matched non-diabetic comparators, in the national cancer register. Results and conclusions: The risk ratio for any cancer, adjusted for deprivation, was 0.99 (95%CI 0.90–1.09). Significantly increased risks were observed for pancreatic, liver and colon cancer.
ISSN:0007-0920
1532-1827
DOI:10.1038/sj.bjc.6605240